BRUSSELS: The International Federation for Animal Health (IFAH) hired Grayling to conduct a global communications study to better understand how key stakeholders view the animal health industry.
IFAH is nonprofit which represents manufacturers of veterinary medicines, vaccines, and animal health products such as Bayer HealthCare, Novartis, and Pfizer.
Grayling, based in London, won the project-based contract in March over four other undisclosed agencies, said Kim Hardie, communications director for IFAH/IFAH-Europe. The contract ends in April.
“Grayling had the best understanding of animal health-relevant issues; a main decider was the understanding of the needs of an association like ours and the benefits of an exercise as the one we were planning to undertake,” Hardie said by e-mail.
She declined to disclose the budget.
The firm will survey IFAH's key international stakeholders and consumers to help the organization plan its global communications strategy. Stakeholders include the World Health Organization, Food and Agriculture Association of the United Nations, and World Trade Organization.
The study involves work in North and South America, Europe, and Japan.
“We realize that the role our industry plays in society is not always obvious," said Hardie by e-mail. "The study will help us see where we need to focus our future communications so we can improve society's understanding of the need for safeguarding animal health.”
The study findings will be presented this spring. Grayling will likely provide support for the release of the findings but tactics have not been decided, according to Jonathan Shillington, MD of IR at Grayling.